Investors & Media

Overview

Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for nocturnal leg cramps, cramps and spasms associated with severe neuromuscular conditions such as MS and ALS, and exercise-associated muscle cramps. Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.

Stock Quote
FLKS (Common Stock)
Price & Exchange$4.02 (US Dollar)
NASDAQ GS
Change (%) Stock is Down 0.06 (1.47%)
Volume18,216
Data as of 03/24/17 3:31 p.m. ET
Minimum 20 minute delay
Refresh quote
Webcast ImageWebcast
Flex Pharma Inc at the Oppenheimer & Co. Inc. 27th Annual Healthcare Conference (Replay)
03/21/17 at 10:55 a.m. ET
Flex Pharma Inc at the Oppenheimer & Co. Inc. 27th Annual Healthcare Conference
Tuesday, March 21, 2017 10:55 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Upcoming EventsMore >>
There are currently no events scheduled.
Data Provided by Thomson Reuters